Skip to main content
. 2021 Jan 12;40(8):3053–3065. doi: 10.1007/s10067-020-05545-y

Fig. 3.

Fig. 3

The efficacy evaluation of IL-17A inhibitors in AS. Forest plots of ORs for ASAS20 response (A), ASAS40 response (B), ASAS5/6 response (C), and ASAS partial remission (D) in patients with AS. Forest plots of MD for BASDAI (E) in patients with AS